Shares of Biocon may see buying activity, as the company on Monday informed the exchanges of a clean chit it received from the USFDA. In a notification to the exchanges, the biotechnology company said its active pharmaceutical ingredients facility at Visakhapatnam, Andhra Pradesh, has completed the USFDA audit from September 11 to 15 without any observations. Biocon had acquired the unit from Acacia Lifesciences in October 2015.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.